Multiple Sclerosis

Fumarox 240 delayed release capsule

Fumarox 120 delayed release capsule
HF0718OA4677/082025
18/08/2026

Multiple Sclerosis

Fumarox 240 delayed release capsule

Product Composition :

Each capsule contains Dimethyl fumarate 120 or 240 mg Starting dose is 120mg twice a day, orally for 7 days Maintenance dose after 7 days, 240 mg twice a day, orally

Product Details :

Fumarox is indicated for the treatment of relapsing forms of multiple sclerosis to include clinically isolated syndrome, relapsing remitting disease and active secondary progressive disease in adults.

Related Products

Ready to Partner with Elixir Pharma?

Join us in our mission to transform healthcare across Egypt, the Middle East, and Africa.